Compare OGN & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | FRPT |
|---|---|---|
| Founded | 1923 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 2020 | 2014 |
| Metric | OGN | FRPT |
|---|---|---|
| Price | $13.89 | $67.92 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 18 |
| Target Price | $10.33 | ★ $84.81 |
| AVG Volume (30 Days) | ★ 2.3M | 1.0M |
| Earning Date | 10-30-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | N/A | ★ 183.87 |
| EPS | 1.56 | ★ 1.88 |
| Revenue | ★ $6,216,000,000.00 | $1,102,015,000.00 |
| Revenue This Year | N/A | $12.41 |
| Revenue Next Year | $2.07 | $8.53 |
| P/E Ratio | ★ $8.91 | $34.79 |
| Revenue Growth | N/A | ★ 13.01 |
| 52 Week Low | $5.69 | $46.45 |
| 52 Week High | $13.90 | $86.00 |
| Indicator | OGN | FRPT |
|---|---|---|
| Relative Strength Index (RSI) | 64.32 | 54.95 |
| Support Level | $13.72 | $66.32 |
| Resistance Level | N/A | $70.24 |
| Average True Range (ATR) | 0.05 | 2.81 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 90.63 | 63.26 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.